Objective: The association between secundum atrial septal defects (ASD) and asthmalike dyspnea with consequent long-term pulmonary inhalant use, is poorly understood in adult ASD patients. Airway hyperresponsiveness is suggested to be the underlying mechanism of cardiac asthma from mitral valve disease and ischemic cardiomyopathy.
| INTRODUC TI ON
Secundum atrial septal defects (ASDs) are the second most common congenital heart defects, and may manifest late into adulthood with symptoms of dyspnea or palpitations. 1 The association between ASD and asthma-like dyspnea, such as wheezing and chest tightness, is commonly acknowledged in the pediatric community, 2 yet unequally established in adult cardiology. The prevalence of asthma-like symptoms and pulmonary inhalant use in an adult ASD study cohort has recently been suggested in a questionnaire-based study of 80 adult ASD patients in which one-third of patients reported wheezing and chest tightness and 20% used bronchodilators. 3 Also, in a multicenter population-based study (unpublished data), use of pulmonary inhalants was found to be twice as high in adult ASD patients compared to the general population, both before and long after shunt repair. As of now, however, the possible underlying mechanism of asthma-like dyspnea with consequent long-term pulmonary inhalant use in adult ASD patients still remains unclear.
Among cardiac diseases, asthma-like symptoms known as "cardiac asthma" are extensively described in patients with chronic heart failure with or without mitral valve disease, [4] [5] [6] [7] [8] [9] and airway hyperresponsiveness has been suggested to be the underlying mechanism of these symptoms. Airway hyperresponsiveness is characterized by more sensitive and increased airway narrowing to nonspecific stimuli that normally lead to little or no airway response. 10 Unlike in bronchial asthma, airway hyperresponsiveness can exist without a (family) history of atopy like allergic rhinitis or atopic eczema, or evidence of eosinophilic airways inflammation. 11 Since ASD patients may present with asthma-like dyspnea, we hypothesized that airway hyperresponsiveness may also be found in adult ASD patients. Hence, our aim was to study airway responsiveness in adult ASD patients before percutaneous closure and at short-and long-term postprocedural follow-ups.
| ME THODS

| Study design
In this prospective observational study, we evaluated consecutive adult patients with secundum ASD referred for percutaneous closure in the Center for Congenital Heart Disease Amsterdam Leiden within a period of 13 months (2014-2015) . Indication for ASD closure was decided by our Grown-Up Congenital Heart team based on current guidelines. 12 Pulmonary function testing and echocardiographic imaging were performed pre-and at six-month postprocedural follow-up as routine clinical work-up. Pulmonary function testing was repeated at 2-year postprocedural follow-up as part of this study.
Additional cardiovascular magnetic resonance (CMR) imaging was performed at the physician's discretion. The study cohort comprised patients who had complete baseline pulmonary testing and who underwent successful percutaneous ASD closure. This study conforms to the 1975 Declaration of Helsinki and all patients provided informed consent according to local medical ethical regulations. 
| ASD closure
| Methacholine challenge testing
Standardized spirometry was performed on a MasterScreen PFT (Jaeger, Wurzburg, Germany) and predicted values were based on age, sex, and height. 
| Questionnaire
The validated Dutch version of the European Community
Respiratory Health Survey (ECRHS) was conducted before any spirometry, enquiring about symptoms of wheezing not associated with the flu, (nocturnal) chest tightness, resting/exercise/nocturnal dyspnea, (nocturnal) cough, and/or phlegm during winter, troubled breathing, diagnosed asthma, nasal allergies, hay fever, and eczema. 17 All questions refer to symptoms in the previous 12 months or 6 months, at baseline and follow-up, respectively.
Asthma definition and classification were based on the Global
Initiative for Asthma guidelines. 
| Statistical analysis
Baseline characteristics, hemodynamics, and pulmonary function parameters are presented as mean ±standard deviation, median test. Correlations were linearly tested unless mentioned otherwise.
A two-sided P value <.05 was considered statistically significant. All analyses were performed using IBM SPSS Statistics for Windows, Version 23 (IBM Corp., Armonk, New York).
The primary outcome of this study was airway hyperresponsiveness at baseline before ASD closure. Secondary outcomes include airway responsiveness at 6-month and 2-year postprocedural follow-up, and ventilatory and hemodynamic changes from baseline to 6 months after percutaneous ASD closure. This hypothesis-generating study did not allow for sample size specification. Instead, a post hoc power analysis was conducted using G*Power software (Heinrich-Heine-Universität Düsseldorf, Düsseldorf, Germany) set at alpha error 0.05 (one-sided) and a 35% prevalence of airway hyperresponsiveness in the general population. A power of ≥80% was considered a significant statistical power for the reported prevalence of airway hyperresponsiveness in this study.
| RE SULTS
| Study cohort
Following the Grown-Up Congenital Heart team decision, 41 adults were consecutively planned for percutaneous ASD closure in a 13-month period. Ten patients had incomplete baseline pulmonary assessment, therefore 31 ASD patients with complete preprocedural spirometry and bronchoprovocation testing formed the study cohort ( Figure S1 ).
Baseline characteristics are shown in Table 1 . The mean age was 49 ± 15 years, 65% were female, and 84% were repaired for right ventricular dilatation with a pulmonary-to-systemic-flow ratio of 1.9 ± 0.9. Based on the Global Initiative for Asthma guidelines, 4(13%) patients had diagnosed asthma (n = 2 mild, n = 2 moderate) and 11(35%) patients had a self-reported history of either allergic rhinitis, atopic eczema, or insect allergy. Ten (32%) patients had symptoms of wheezing, chest tightness, and/or nocturnal dyspnea.
An episode of resting dyspnea was present in 21 (68%) patients, and exertional dyspnea was reported by 22 (71%) patients. Four patients were on current respiratory medicine (n = 3 corticosteroids, n = 1 short-acting ß 2 -agonist) and another two used low-dose oral glucocorticoids for comorbidity.
| Airway responsiveness
Of the 30 patients with bronchoprovocation testing (n = 1 excluded for FEV 1 <70%), 19 patients had airway hyperresponsiveness, corresponding to a prevalence of 63% (95%CI 45%-81%) in this study population. This yielded a post hoc statistical power of 89%. The dose-response curve of all individual patients is shown in Figure 1A . Table 2 shows the paired ventilatory and hemodynamic changes from baseline to 6-month postprocedural follow-up (mean follow-up 6.0 ± 1.0 months), as measured by spirometry and cardiac imaging, respectively.
| Effect of closure
At baseline spirometry, FEV 1 was 3.0 ± 0.9L/s (98% ± 15% predicted) with a FEV 1 /forced vital capacity index of 0.8 ± 0.07 (99% ± 7.8% predicted). FEV 1 was associated with baseline symptoms of wheezing (r 2 =0.22; P = .008). Postprocedural improvements in spirometry were seen most notably in FEV 1 (98% ± 15%-101% ± 14%; P = .04), forced vital capacity (103% ± 16%-108% ± 15%; P < .001) and inspiratory vital capacity (100% ± 16%-103% ± 15%; P = .03).
Low baseline spirometry values were associated with baseline exertional dyspnea (P < .01) and its postprocedural resolution (P ≤ .01). 
| D ISCUSS I ON
This study is the first to report a high prevalence of airway hyperresponsiveness in a cohort of unrepaired adult ASD patients. 
| Airway hyperresponsiveness
Increased airway responsiveness to nonspecific stimuli is one of the major defining features of asthma, but not pathognomonic for it. 11 In the general adult population the prevalence of airway responsiveness is 10%-16% (max. 25%-35% as defined by a ≤ 10% FEV 1 decline), 20, 21 and its risk factors include age, female gender, atopic constitution, respiratory tract infection, current smoking, and genetic predisposition. 22 The 63% (95%CI 45%-81%) Neither airway reactivity (dose-response slope) nor airway sensitivity (estimated by the methacholine concentration at which FEV 1 decreases ≥20%) improved at six-month or two-year follow-up after successful ASD closure. Our data are consistent with studies reporting unchanged airway hyperresponsiveness after treatment for mitral valve disease, [24] [25] [26] although some improvement in airway sensitivity was seen. A previous study in acute on chronic heart failure patients also showed no alteration in responsiveness despite adequate diuretic therapy and significant radiological improvement. 27 Thus, pathophysiology inherent to such cardiac diseases seems to maintain airway hyperresponsiveness despite adequate therapy, suggesting that flow-mediated pulmonary vascular distention in ASD patients may be a trigger rather than a cause of airway hyperresponsiveness.
| Asthma-like symptoms
The Global Initiative for Asthma guideline defines asthma by respiratory symptoms such as wheezing, chest tightness, cough and shortness of breath that vary in duration and intensity, accompanied by variable airflow limitation. 11 In the present study, wheezing, chest tightness, and cough were indeed predominantly reported by hyperresponsive ASD patients, and parallel to the unchanged airway responsiveness postclosure, these asthma-like symptoms did not significantly resolve after shunt repair (Figure 2) . Therefore, the present study confirms the association between secundum ASD and asthma-like symptoms, TA B L E 1 Baseline characteristics of the study cohort and additionally provides data that suggests that airway hyperresponsiveness is one of the possible underlying mechanisms.
| Effects of ASD closure
The most frequently reported symptoms in this study cohort were troubled breathing and exertional dyspnea which, regardless of airway responsiveness, resolved significantly after successful closure.
The corresponding improvement in FEV 1 and forced and inspiratory vital capacity significantly correlated with reverse right heart remodeling and systolic pulmonary artery pressure decline at 6-month follow-up. With or without the presence of pulmonary hypertension, left-to-right shunts are known to increase pulmonary apical perfusion by capillary recruitment. 28 Indeed, the observed significant reverse remodeling after percutaneous closure may suggest that spatial reduction in pulmonary vascular volume and peripheral airway caliber improves vital capacity. 
| Clinical implications
The present study reports a high prevalence of airway hyperresponsiveness in a cohort of adult ASD patients, and proposes airway hyperresponsiveness as a possible mechanism for asthma-like symptoms that potentially require pulmonary inhalant use, both before and long after closure. Characteristic nonspecific triggers for bronchospasm such as cold or dry air, abrupt temperature changes, smoke, and exercise may induce asthma-like symptoms in ASD patients, regardless of repair status. Unlike in bronchial asthma,
11
ASD-associated asthma-like symptoms are not necessarily episodic over merely few hours to days, but can manifest with progressive TA B L E 2 Ventilatory and hemodynamic parameters before and 6 months after successful ASD closure 
| CON CLUS IONS
This is the first study to show an association between secundum ASD and airway hyperresponsiveness, and confirms the association 
